Metoclopramide-induced sulfhemoglobinemia.
Metoclopramide, a drug with oxidant activity, has infrequently been reported to cause methemoglobinemia in infants. We present a unique case in which a patient on chronic metoclopramide therapy developed sulfhemoglobinemia that resolved with subsequent discontinuation of the drug. Mechanisms that may be important in the formation of sulfhemoglobin also are discussed.
Van Veldhuizen
P J
PJ
Department of Medicine, Veteran Affairs Medical Center, Kansas City, Missouri, USA.
Wyatt
A
A
D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000009:adverse effects*; D008875:Middle Aged; D013436:Sulfhemoglobinemia / Q000139:chemically induced*
D008787:Metoclopramide